GlassScriptPhysician profile
Jennifer A Lintz
NPI 1003992082
$1,249.79
in general payments reported to CMS, 2019-2025
11 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.48 · 2020: $146 · 2021: $210 · 2022: $131 · 2023: $169 · 2024: $352 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $254.07 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $209.38 | 2019-2024 | Acuvue |
| Alcon Vision LLC | $198.39 | 2020-2025 | Precision7, Total30, Precision 7 |
| Bausch & Lomb Americas INC. | $196.97 | 2022-2025 | Infuse, Alden Scleral Zenlens |
| Lkc Technologies, INC. | $181.97 | 2024 | |
| Lombart Brothers, INC. | $69.00 | 2024 | Opd-III |
| Coopervision INC. | $58.70 | 2019-2025 | Myday Contact Lens |
| Biotissue Holdings INC. | $33.21 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $20.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.03 | 2021 | |
| Allergan, INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lintz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.